BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE
批准号:
6174722
负责人:
ALAN Paul KOZIKOWSKI
金额:
$27.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2002-07-31
中文摘要
描述:(申请人摘要)
全世界的可卡因滥用都需要立即治疗。
在这个方向上,我们最近发现了一个基于piperidne的类似物
可卡因(特别是1-甲基-4-(4-氯苯基)的反式异构体)
胡椒碱-3-羧酸甲酯)与可卡因结合
对可卡因有类似亲和力的识别位点;此外,这
化合物对多巴胺的吸收起到了抑制作用。尽管有
化合物的效力,已经观察到在歧视研究中
大鼠,该化合物仅表现出微弱的可卡因-苯丙胺样作用。
与可卡因不同的是,这种化合物具有微弱的运动刺激作用,而且
由大鼠自行给药。这些结果似乎很有希望从
发现治疗药物滥用的可能药物的观点。
为了妥善跟进这些令人鼓舞的初步结果,
研究人员计划在体外进行进一步的化学模拟合成
药理研究和活体动物实验
4-苯基哌啶类似物,目的是改进生物
这个化合物的简介。
在这项建议的范围内,我们打算继续
以下是具体目标:
1.按顺序进行额外的构效关系研究
以确定他们正在尽可能地推进最好的化合物(S)
药物。这些研究将包括制备铅结构。
光学纯形式,以及相关类似物的设计和合成
体现以下结构变化:a)性质的修改
和苯环承担的取代基的位置;b)取代
其他烷基和磺酰基的N-甲基,以及
CH2和O取代NME的异构性;c)取代酯基
由烷基和烯基组成。
2.对所有新合成的类似物进行药理表征
体外结合实验及对5-羟色胺、去甲肾上腺素和多巴胺的抑制作用
领悟。
3.对于选定的化合物,评价其静脉注射的安全性
候选化合物,以及符合安全标准的化合物,
进行运动活动测试。
4.对于符合既定标准的化合物,进一步评估其行为
静脉给药动物的药理学研究进展
自我管理和药物歧视程序。
英文摘要
DESCRIPTION: (Applicant's Abstract)
Immediate therapies are needed for the treatment of cocaine abuse worldwide.
In this direction, we recently identified a piperidne-based analog of
cocaine (specifically, the trans isomer of 1-methyl-4-(4-chlorophenyl)
piperdine-3-carboxylic acid methyl ester) that binds to the cocaine
recognition site with comparable affinity to cocaine; additionally, this
compound acts as an inhibitor of dopamine uptake. In spite of the
compound's potency, it has been observed that in discrimination studies in
rats, the compound exhibits only weak cocaine-amphetamine-like effects.
Unlike cocaine, this compound has weak motor stimulant effects and is not
self administered by rats. These results appear to be promising from the
standpoint of discovering a possible medication for drug abuse treatment.
In order to properly follow up on these encouraging preliminary results, the
investigators plan to conduct further chemical analog synthesis, in vitro
pharmacological studies, and in vivo animal experiments on the
4-phenylpiperidine analogs with the objective to improve upon the biological
profile of this compound.
Within the context of this proposal, it is our intention to pursue the
following specific aims:
1. To conduct additional structure-activity relationship studies in order
to establish that they are advancing the best compound(s) as possible
medications. These studies would include preparation of the lead structure
in optically pure form, and the design and synthesis of related analogs
embodying a the following structural changes: a) modification of the nature
and position of the substituent borne by phenyl ring; b) replacement of the
N-methyl group by other alkyl groups and sulfonyl groups, as well as
isosteric replacement of NMe by CH2 and O; c) replacemnt of the ester group
by alkyl and alkenyl groups.
2. To characterize all newly synthesized analogs pahamacologically in in
vitro binding experiments, and for the inhibition of the 5HT, NE, and DA
uptake.
3. For selected compounds, to evaluate the intravenous safety of the
candidate compounds, and for compounds meeting the saftey critieria, to
carry out locomotion activity assays.
4. For compounds meeting set criteria, to further evaluate their behavioral
pharmacological profile in animals using intravenous drug
self-administration and drug discrimination procedures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemistry and Biology of 5-HT2C Receptor Ligands for Drug Abuse
-
批准号:7321298
-
项目类别:
-
资助金额:$50.78万
-
财政年份:2007
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Molecular Interventions for Bipolar Disorder
-
批准号:7189548
-
项目类别:
-
资助金额:$44.4万
-
财政年份:2006
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
PKC Modulators for the Treatment of Alzheimer's disease
-
批准号:6966114
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2005
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
PKC Modulators for the Treatment of Alzheimer's disease
-
批准号:7249449
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2005
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
PKC Modulators for the Treatment of Alzheimer's disease
-
批准号:7102664
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2005
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Chemistry and Pharmacology of a New Nicotine Ligands
-
批准号:7084395
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Chemistry and Pharmacology of a New Nicotine Ligands
-
批准号:6679753
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2003
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Chemistry and Pharmacology of a New Nicotine Ligands
-
批准号:6806946
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2003
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Chemistry and Pharmacology of a New Nicotine Ligands
-
批准号:7250073
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
Chemistry and Pharmacology of a New Nicotine Ligands
-
批准号:6915471
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2003
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY
-
批准号:6513211
-
项目类别:
-
资助金额:$0.2万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
NEW LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS
-
批准号:6393808
-
项目类别:
-
资助金额:$34.91万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY
-
批准号:6835432
-
项目类别:
-
资助金额:$30.78万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
NEW LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS
-
批准号:2842873
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY
-
批准号:6164295
-
项目类别:
-
资助金额:$29.26万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY
-
批准号:6362682
-
项目类别:
-
资助金额:$30.09万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
NEW LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS
-
批准号:6187312
-
项目类别:
-
资助金额:$34.04万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY
-
批准号:2727755
-
项目类别:
-
资助金额:$28.87万
-
财政年份:1999
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE
-
批准号:6378737
-
项目类别:
-
资助金额:$28.63万
-
财政年份:1997
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE
-
批准号:2467371
-
项目类别:
-
资助金额:$29.15万
-
财政年份:1997
-
负责人:ALAN Paul KOZIKOWSKI
-
依托单位:
国内基金
海外基金
抗可卡因(Cocaine)抗体酶的研制及实验研究
-
批准号:39570633
-
项目类别:面上项目
-
资助金额:8.5万元
-
批准年份:1995
-
负责人:段燕文
-
依托单位: